A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
Maria Vadalà,1,2 Valentina Sunseri Trapani,1 Giulia Guarrasi,1 Nicasio Ventura,1 Massimo Castellucci,1 Salvatore Cillino1 1Biomedicine, Neuroscience and Advanced Diagnostic Department, University of Palermo, Palermo, Italy; 2IEMEST, Euro-Mediterranean Institute of Science and Technology,...
Saved in:
Main Authors: | Vadalà M, Sunseri Trapani V, Guarrasi G, Ventura N, Castellucci M, Cillino S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/0df633b46a2245c2b8035d9759a7fbe4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
by: Urbančič M, et al.
Published: (2019) -
Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
by: Chhablani J, et al.
Published: (2018) -
Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
by: Udaondo P, et al.
Published: (2021) -
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
by: Coelho J, et al.
Published: (2019) -
Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
by: Laine I, et al.
Published: (2017)